We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-7.92%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$670M
AUM Growth
-$18.2M
Cap. Flow
-$335M
Cap. Flow %
-50.06%
Top 10 Hldgs %
86.43%
Holding
215
New
27
Increased
46
Reduced
57
Closed
68

Top Buys

Rank Stock Value
1
NRXP icon
NRX Pharmaceuticals
NRXP
+$2.55M
2
TANH icon
Tantech Holdings
TANH
+$2.26M
3
AGTC
Applied Genetic Technologies Corporation
AGTC
+$1.76M
4
ZVRA icon
Zevra Therapeutics
ZVRA
+$1.52M
5
NBEV
NewAge, Inc. Common Stock (Delaware)
NBEV
+$1.12M

Top Sells

Rank Stock Value
1
BTBT icon
Bit Digital
BTBT
+$17.7M
2
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$10.2M
3
ROI
RiskOn International, Inc. Common Stock
ROI
+$7.16M
4
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$5.75M
5
SLAI
SOLAI Ltd ADS
SLAI
+$5.55M

Sector Composition

Rank Sector Weight
1 Healthcare 7.59%
2 Technology 1.45%
3 Financials 0.54%
4 Consumer Discretionary 0.53%
5 Consumer Staples 0.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PMCB icon
101
PUT
PharmaCyte Biotech
PMCB
$6.29M
$158K 0.02%
687
+22
+3% +$49
CINGW icon
102
Cingulate Inc Warrants
CINGW
$42.9K
$156K 0.02%
555,754
+55,754
+11% +$24.1K
CTRM icon
103
PUT
Castor Maritime
CTRM
$18.2M
$152K 0.02%
82
-54
-40% -$834
IKT icon
104
Inhibikase Therapeutics
IKT
$352M
$147K 0.02%
16,500
-54,336
-77% -$437K
ORIO
105
PUT
Orion Digital Corp
ORIO
$15.6M
$145K 0.02%
166
+3
+2% +$22
PPBT
106
PUT
Purple Biotech
PPBT
$1.32M
$138K 0.02%
2
-3
-60% -$1.94K
BEATW icon
107
Heartbeam Inc Warrant
BEATW
$44.3K
$133K 0.02%
360,458
+67
+0% +$36
MODD icon
108
Modular Medical
MODD
$11.4M
$133K 0.02%
+1,010
New +$118K
CTRM icon
109
Castor Maritime
CTRM
$18.2M
$126K 0.02%
6,842
-24,422
-78% -$377K
IMPP icon
110
Imperial Petroleum
IMPP
$213M
$125K 0.02%
+5,764
New +$163K
ATOS icon
111
CALL
Atossa Therapeutics
ATOS
$23.4M
$120K 0.02%
64
-86
-57% -$1.75K
MTC icon
112
MMTec
MTC
$369M
$114K 0.02%
2,308
-7,135
-76% -$342K
NOVN
113
DELISTED
Novan, Inc. Common Stock
NOVN
$114K 0.02%
28,838
+9,706
+51% +$35.7K
BKYI
114
BIO-key International
BKYI
$4.56M
$105K 0.02%
243
+46
+23% +$18.6K
PPBT
115
Purple Biotech
PPBT
$1.32M
$105K 0.02%
+133
New +$85.8K
KRBP
116
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$91K 0.01%
3,559
-17,274
-83% -$511K
WIMI
117
WiMi Hologram Cloud
WIMI
$22.1M
$89K 0.01%
3,340
+1,920
+135% +$51.7K
WIMI
118
PUT
WiMi Hologram Cloud
WIMI
$22.1M
$89K 0.01%
33
-165
-83% -$4.44K
ADTX
119
PUT
DELISTED
ADITXT INC
ADTX
– –
0
– –
ATHX
120
PUT
DELISTED
Athersys, Inc. Common Stock
ATHX
$86K 0.01%
12
– –
RKDA icon
121
PUT
Arcadia Biosciences
RKDA
$1.44M
$77K 0.01%
14
+1
+8% +$48
ALPP
122
PUT
DELISTED
Alpine 4 Holdings Inc
ALPP
$77K 0.01%
92
+74
+411% +$905
EQOS
123
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$76K 0.01%
33,887
+13,088
+63% +$24.8K
BIOC
124
DELISTED
Biocept, Inc.
BIOC
$71K 0.01%
1,017
+395
+64% +$31K
HMCOW
125
DELISTED
HumanCo Acquisition Corp. Warrant
HMCOW
$64K 0.01%
200,314
– –
3 4
5
6 7

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AB
Aozora Bank Tokyo, Japan $43.6M AUM 1.15% 1-Year Est. Return

Sabby Management's Q1 2022 Portfolio in Review

As of Q1 2022, Sabby Management held 215 positions worth $670M, down 2.6% from $688M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Sabby Management withdrew a net $335M in Q1 2022, closing 68 positions and reducing 57 holdings. Its most notable exit was Bit Digital, an estimated $17.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 7.4% a quarter earlier, followed by Technology and Financials.

Against the trend, Sabby Management opened a new position in NRX Pharmaceuticals worth $1.92M.

  • Sabby Management's largest Q1 2022 buy was NRX Pharmaceuticals: 78,247 shares worth $1.92M.
  • Sabby Management added most to Tantech Holdings in Q1 2022, an estimated $2.26M increase.
  • Sabby Management's biggest Q1 2022 reduction was SOLAI Ltd ADS, cutting an estimated $5.55M.
  • Sabby Management fully exited Bit Digital in Q1 2022, selling an estimated $17.7M.
  • Sabby Management's ten largest holdings make up 86% of its $670M portfolio in Q1 2022.
  • Sabby Management opened 27 new positions and closed 68 in Q1 2022.
  • Sabby Management's portfolio value fell 2.6% quarter-over-quarter to $670M.

Based on Sabby Management's 13F filing for Q1 2022, filed 16 May 2022.